| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 03/09/2006 | WO2006024741A2 Hybrid qa molecules wherein q is an aminoquinoline and a is an antibiotic residue, their synthesis and their uses as antibacterial agent |
| 03/09/2006 | WO2006004924A3 Imidazolo-related compounds, compositions and methods for their use |
| 03/09/2006 | WO2005105770A3 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives |
| 03/09/2006 | WO2005063239A9 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
| 03/09/2006 | WO2005058841A3 Hiv protease inhibiting compounds |
| 03/09/2006 | US20060052611 Mitotic kinesin inhibitors |
| 03/09/2006 | US20060052606 Factor xa Inhibitors |
| 03/09/2006 | US20060052600 Amino-functional chalcones |
| 03/09/2006 | US20060052597 Aryloxyalkylamine derivatives as h3 receptor ligands |
| 03/09/2006 | US20060052419 Use of pyridly amides as inhibitors of angiogenesis |
| 03/09/2006 | US20060052417 N3-((1-(2-Oxo-2-(phenylamino)ethyl)-4-piperidyl)methyl)- 1-(1-methylethyl)-1H-indazole-3-carboxamide; antiarthritic agents; rheumatic diseases; osteoarthritis; fibromyaleia;anticarcinogenic agents, pain; neuropathic pain; immunoincompetance; trauma; antiischemic agents; multiple sclerosis |
| 03/09/2006 | US20060052413 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 03/09/2006 | US20060052411 Immunosuppressants, analgesics, antiinflammatory agents |
| 03/09/2006 | US20060052408 Cyclopropyl compounds as ccr5 antagonists |
| 03/09/2006 | US20060052398 Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same |
| 03/09/2006 | US20060052396 Arylamines for the treatment of conditions associated with gsk-3 |
| 03/09/2006 | US20060052392 Isoindoline derivative |
| 03/09/2006 | US20060052388 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |
| 03/09/2006 | US20060052384 Aryl piperidine derivatives as inducers of ldl-receptor expression for the treatment of hypercholesterolemia |
| 03/09/2006 | US20060052379 Pyridazin-3(2h)-one derivatives as pde4 inhibitors |
| 03/09/2006 | US20060052375 Bis-alkylbenzylamines |
| 03/09/2006 | US20060052374 Amino-tetrazole analogues and methods of use |
| 03/09/2006 | US20060052366 Pyridine derivatives as fungicidal compounds |
| 03/09/2006 | US20060052365 Protease inhibitors |
| 03/09/2006 | US20060052345 Quinazolinone compounds as calcilytics |
| 03/09/2006 | US20060052314 Pharmaceutical combination |
| 03/09/2006 | US20060052311 Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (IAP) |
| 03/09/2006 | US20060052265 Use of metal complex compounds as oxidation catalysts |
| 03/09/2006 | US20060051879 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 03/09/2006 | DE4344422B4 Pyri(mi)din-Derivate und flüssigkristallines Medium Pyri (mi) dine derivatives and liquid crystalline medium |
| 03/09/2006 | CA2578955A1 Isoindolin-1-one derivatives |
| 03/09/2006 | CA2578746A1 Chemical compounds |
| 03/09/2006 | CA2578630A1 Pyrimidinylimidazoles as tgf-beta inhibitors |
| 03/09/2006 | CA2578628A1 Pyrimidinylpyrazoles as tgf-beta inhibitors |
| 03/09/2006 | CA2578604A1 Piperidine derivative or pharmaceutically acceptable salt thereof |
| 03/09/2006 | CA2578441A1 Pyrimidine sulphonamide derivatives as chemokine receptor modulators |
| 03/09/2006 | CA2577398A1 Urea derivatives as calcium channel blockers |
| 03/09/2006 | CA2577301A1 Substituted biaryl piperazinyl-pyridine analogues |
| 03/09/2006 | CA2577275A1 Quinazolinone derivatives and their use as b-raf inhibitors |
| 03/09/2006 | CA2576973A1 Benzamide compounds |
| 03/09/2006 | CA2576717A1 Pyrrole derivatives, their preparation and their therapeutic use |
| 03/09/2006 | CA2572442A1 Hybrid qa molecules wherein q is an aminoquinoline and a is an antibiotic residue, their synthesis and their uses as antibacterial agent |
| 03/09/2006 | CA2571989A1 Modulators of nuclear receptors |
| 03/08/2006 | EP1632483A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 03/08/2006 | EP1632479A2 Piperazine derivatives useful as ccr5 antagonists |
| 03/08/2006 | EP1632477A1 Benzamide derivative or salt thereof |
| 03/08/2006 | EP1631567A2 Heterocyclic n-aryl carboxamides as cytokine inhibitors |
| 03/08/2006 | EP1631566A1 2-anilino-4-(imidazol-5-yl)-pyrimidine derivatives and their use as cdk (cdk2) inhibitors |
| 03/08/2006 | EP1631565A1 Piperazine-alkyl-ureido derivatives |
| 03/08/2006 | EP1631564A1 Method for preparing fused oxazinones |
| 03/08/2006 | EP1631560A2 C-fms kinase inhibitors |
| 03/08/2006 | EP1631554A2 Nitrogen-containing heteroaryl derivatives for the treatment of hcv-infection |
| 03/08/2006 | EP1631551A2 Isoquinoline derivatives and their use as gfat inhibitors |
| 03/08/2006 | EP1631548A2 Inhibitors of akt activity |
| 03/08/2006 | EP1631292A1 4-anilino-quinazoline derivatives as antiproliferative agents |
| 03/08/2006 | EP1631286A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 03/08/2006 | EP1631285A1 Therapeutic agents useful for treating pain |
| 03/08/2006 | EP1631284A2 Solid-state forms of 5-(difluoromethoxy)-2-((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-1h-benzimidazole (pantoprazole) sodium aqua complexes |
| 03/08/2006 | EP1539734B1 Piperidine quinolyl propyl derivatives and use thereof as antimicrobial agents |
| 03/08/2006 | EP1482924A4 Cathepsin cysteine protease inhibitors |
| 03/08/2006 | EP1451167B1 Phenylalkynes |
| 03/08/2006 | EP1445252B1 Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
| 03/08/2006 | EP1406628B1 Tetrahydroquinoline derivatives |
| 03/08/2006 | EP1404667B1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 03/08/2006 | EP1387839B1 Process for the production of quinazolines |
| 03/08/2006 | EP1353908B1 Processes and synthetic intermediates for preparing n-arylacridancarboxylic acid derivatives |
| 03/08/2006 | EP1347966B1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 03/08/2006 | EP1318995B1 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
| 03/08/2006 | EP1313721B1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 03/08/2006 | EP1276722B1 Naphthamidine urokinase inhibitors |
| 03/08/2006 | EP1242411B1 Indole derivatives for the treatment of depression and anxiety |
| 03/08/2006 | EP1178967B1 Quinoline derivatives as inhibitors of mek enzymes |
| 03/08/2006 | EP1176959B1 Novel prolines as antimicrobial agents |
| 03/08/2006 | CN1745082A Solvent-free process for the preparation of diketopyrrolopyrrole derivatives |
| 03/08/2006 | CN1745077A 促旋酶抑制剂及其用途 Gyrase inhibitors and their use |
| 03/08/2006 | CN1745076A Malonamide derivatives as gamma-secretase inhibitors |
| 03/08/2006 | CN1745074A 5-HT receptor ligands and uses thereof |
| 03/08/2006 | CN1745071A Novel ethylenediamine derivatives |
| 03/08/2006 | CN1745070A 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors |
| 03/08/2006 | CN1745065A 4-oxo-3-(1-oxo-1h-isoquinolin-2-ylacetylamino)-pentanoic acid ester and amide derivatives and their use as aspartic specifity cysteine proteinase inhibitors |
| 03/08/2006 | CN1745063A Compound inhibiting dipeptidyl peptidase iv |
| 03/08/2006 | CN1744930A 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 03/08/2006 | CN1744895A N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines |
| 03/08/2006 | CN1744894A 3-(2-hydroxy-phenyl)-1H-pyrazole-4-carboxylic acid amide derivatives as HSP90 inhibitor for the treatment of cancer |
| 03/08/2006 | CN1743382A Cationic diazo compounds, compositions comprising them as direct dye, process for dyeing keratin fibers and device therefor |
| 03/08/2006 | CN1743315A 2-substituted-4,4,5,5-tetramethyl-1-hydroxyimidazoline, and its synthesis and use |
| 03/08/2006 | CN1743302A Arylpiperazines having 5-hydroxyl-typtamine activity |
| 03/08/2006 | CN1244666C Fluorescent maleimides and uses thereof |
| 03/08/2006 | CN1244576C Chemical compounds |
| 03/08/2006 | CN1244565C New asymmetric process for preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
| 03/08/2006 | CN1244561C Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 03/08/2006 | CN1244558C 1,2-hydrindene or indoline derivative |
| 03/08/2006 | CN1244550C Water-soluble dithioesters and method for polymerization thereof |
| 03/08/2006 | CN1244542C Aromatic amine derivatives having NOS inhibitory effect |
| 03/07/2006 | US7009060 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists |
| 03/07/2006 | US7009056 Glaucoma; multiple sclerosis |
| 03/07/2006 | US7009053 Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same |
| 03/07/2006 | US7009052 such as 1-methyl-2-oxo-4-trifluoromethyl-1,2-dihydroquinoline-6-sulfonic acid phenylamide for use as androgen antagonists |
| 03/07/2006 | US7009051 4-(2-pyridyl) piperazines having 5HT7 receptor agonist activity |
| 03/07/2006 | US7008955 (2-azabicyclo[2.2.1]hept-7yl) methanol derivatives as nicotinic acetylcholine receptor agonists |